Anti-inflammatory activities of an ethanol extract of Ecklonia stolonifera in lipopolysaccharide-stimulated RAW 264.7 murine macrophage cells. 2012

Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
Department of Food Science and Nutrition, Pukyong National University, Busan 608-737, South Korea.

Ecklonia stolonifera is a brown alga that was shown to have antioxidant, anti-inflammatory, tyrosinase inhibitory, and chemopreventive activities. However, the molecular mechanisms underlying its anti-inflammatory activity remain unclear. In this study, we investigated the molecular mechanism of the anti-inflammatory action of E. stolonifera ethanolic extracts (ESE) using lipopolysaccharide (LPS)-stimulated RAW 264.7 cells. ESE inhibited LPS-induced nitric oxide (IC(50) = 72 ± 1.9 μg/mL) and prostaglandin E(2) (IC(50) = 98 ± 5.3 μg/mL) production in a dose-dependent manner and suppressed the expression of inducible nitric oxide synthase and cyclooxygenase-2 in RAW 264.7 cells. ESE also reduced the production of pro-inflammatory cytokines in LPS-stimulated RAW 264.7 cells. LPS-induced nuclear factor-κB (NF-κB) transcriptional activity and NF-κB translocation into the nucleus were significantly inhibited by ESE treatment through the prevention of the degradation of inhibitor κB-α. Moreover, ESE inhibited the activation of Akt, ERK, JNK1/2, and p38 MAPK in LPS-stimulated RAW 264.7 cells. The main components with anti-inflammatory activity in ESE were identified as phlorofucofuroeckol A and B based on the inhibition of NO production. Our results indicate that ESE can be considered as a potential source of therapeutic agents for inflammatory diseases.

UI MeSH Term Description Entries
D008070 Lipopolysaccharides Lipid-containing polysaccharides which are endotoxins and important group-specific antigens. They are often derived from the cell wall of gram-negative bacteria and induce immunoglobulin secretion. The lipopolysaccharide molecule consists of three parts: LIPID A, core polysaccharide, and O-specific chains (O ANTIGENS). When derived from Escherichia coli, lipopolysaccharides serve as polyclonal B-cell mitogens commonly used in laboratory immunology. (From Dorland, 28th ed) Lipopolysaccharide,Lipoglycans
D008264 Macrophages The relatively long-lived phagocytic cell of mammalian tissues that are derived from blood MONOCYTES. Main types are PERITONEAL MACROPHAGES; ALVEOLAR MACROPHAGES; HISTIOCYTES; KUPFFER CELLS of the liver; and OSTEOCLASTS. They may further differentiate within chronic inflammatory lesions to EPITHELIOID CELLS or may fuse to form FOREIGN BODY GIANT CELLS or LANGHANS GIANT CELLS. (from The Dictionary of Cell Biology, Lackie and Dow, 3rd ed.) Bone Marrow-Derived Macrophages,Monocyte-Derived Macrophages,Macrophage,Macrophages, Monocyte-Derived,Bone Marrow Derived Macrophages,Bone Marrow-Derived Macrophage,Macrophage, Bone Marrow-Derived,Macrophage, Monocyte-Derived,Macrophages, Bone Marrow-Derived,Macrophages, Monocyte Derived,Monocyte Derived Macrophages,Monocyte-Derived Macrophage
D000459 Phaeophyceae A class of predominantly marine EUKARYOTA, commonly known as brown algae, having CHROMATOPHORES containing carotenoid PIGMENTS, BIOLOGICAL. ALGINATES and phlorotannins occur widely in all major orders. They are considered the most highly evolved algae because of their well-developed multicellular organization and structural complexity. Algae, Brown,Phaeophyta,Brown Algae
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D000893 Anti-Inflammatory Agents Substances that reduce or suppress INFLAMMATION. Anti-Inflammatory Agent,Antiinflammatory Agent,Agents, Anti-Inflammatory,Agents, Antiinflammatory,Anti-Inflammatories,Antiinflammatories,Antiinflammatory Agents,Agent, Anti-Inflammatory,Agent, Antiinflammatory,Agents, Anti Inflammatory,Anti Inflammatories,Anti Inflammatory Agent,Anti Inflammatory Agents
D016328 NF-kappa B Ubiquitous, inducible, nuclear transcriptional activator that binds to enhancer elements in many different cell types and is activated by pathogenic stimuli. The NF-kappa B complex is a heterodimer composed of two DNA-binding subunits: NF-kappa B1 and relA. Immunoglobulin Enhancer-Binding Protein,NF-kappa B Complex,Nuclear Factor kappa B,Transcription Factor NF-kB,kappa B Enhancer Binding Protein,Ig-EBP-1,NF-kB,NF-kappaB,Nuclear Factor-Kappab,Complex, NF-kappa B,Enhancer-Binding Protein, Immunoglobulin,Factor NF-kB, Transcription,Factor-Kappab, Nuclear,Ig EBP 1,Immunoglobulin Enhancer Binding Protein,NF kB,NF kappa B Complex,NF kappaB,NF-kB, Transcription Factor,Nuclear Factor Kappab,Transcription Factor NF kB
D051379 Mice The common name for the genus Mus. Mice, House,Mus,Mus musculus,Mice, Laboratory,Mouse,Mouse, House,Mouse, Laboratory,Mouse, Swiss,Mus domesticus,Mus musculus domesticus,Swiss Mice,House Mice,House Mouse,Laboratory Mice,Laboratory Mouse,Mice, Swiss,Swiss Mouse,domesticus, Mus musculus

Related Publications

Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
February 2018, BMC complementary and alternative medicine,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
June 2012, International immunopharmacology,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
October 2018, Journal of medicinal food,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
April 2011, Archives of pharmacal research,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
January 2012, Journal of medicinal food,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
September 2021, Biomedicine & pharmacotherapy = Biomedecine & pharmacotherapie,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
August 2016, Inflammation,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
January 2022, BioMed research international,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
September 2020, Food science & nutrition,
Min-Sup Lee, and Mi-Sung Kwon, and Ji-Woong Choi, and Taisun Shin, and Hong Kyoon No, and Jae-Sue Choi, and Dae-Seok Byun, and Jae-Il Kim, and Hyeung-Rak Kim
March 2017, Molecular immunology,
Copied contents to your clipboard!